Institutional Ownership Reviva Pharmaceuticals Hldgs C (RVPHW)
This table provides information about the institutional ownership of Reviva Pharmaceuticals Hldgs C (RVPHW). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 145,111 shares, which have been reported (via 13F filing form) to have a value of $30,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Arena Investors LP
New York, NY |
Aug 14, 2024 Q2 2024 |
85,000
shares
|
$17,850
0.03% of portfolio
|
Q4 2021
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
33,718
shares
|
$7,080
0.0% of portfolio
|
Q2 2023
Reduced 37.92%
|
|
|
Walleye Trading LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
25,727
shares
|
$5,402
0.0% of portfolio
|
Q2 2023
Reduced 37.19%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
666
shares
|
$139
0.0% of portfolio
|
Q3 2024
Reduced 85.71%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|